Frederic Commo
Frederic Commo
Adresse e-mail validée de gustaveroussy.fr
TitreCitée parAnnée
ERCC1 isoform expression and DNA repair in non–small-cell lung cancer
L Friboulet, KA Olaussen, JP Pignon, FA Shepherd, MS Tsao, S Graziano, ...
New England journal of medicine 368 (12), 1101-1110, 2013
3412013
Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER)
F André, T Bachelot, F Commo, M Campone, M Arnedos, V Dieras, ...
The lancet oncology 15 (3), 267-274, 2014
3152014
Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors
NF Delahaye, S Rusakiewicz, I Martins, C Ménard, S Roux, L Lyonnet, ...
Nature medicine 17 (6), 700, 2011
2432011
Immune infiltrates are prognostic factors in localized gastrointestinal stromal tumors
S Rusakiewicz, M Semeraro, M Sarabi, M Desbois, C Locher, R Mendez, ...
Cancer research 73 (12), 3499-3510, 2013
1832013
Enhancement of mRNA in situ hybridization signal by microwave heating.
M Sibony, F Commo, P Callard, JM Gasc
Laboratory investigation; a journal of technical methods and pathology 73 (4 …, 1995
1501995
Next-generation sequencing reveals high concordance of recurrent somatic alterations between primary tumor and metastases from patients with non-small-cell lung cancer
S Vignot, GM Frampton, JC Soria, R Yelensky, F Commo, C Brambilla, ...
J Clin Oncol 31 (17), 2167-2172, 2013
1392013
Mutational profile of metastatic breast cancers: a retrospective analysis
C Lefebvre, T Bachelot, T Filleron, M Pedrero, M Campone, JC Soria, ...
PLoS medicine 13 (12), e1002201, 2016
1202016
Differential expression of biomarkers in primary non-small cell lung cancer and metastatic sites
C Gomez-Roca, CM Raynaud, F Penault-Llorca, O Mercier, F Commo, ...
Journal of Thoracic Oncology 4 (10), 1212-1220, 2009
942009
CFTR, MDR1, and MRP1 immunolocalization in normal human nasal respiratory mucosa
MA Wioland, J Fleury–Feith, P Corlieu, F Commo, G Monceaux, ...
Journal of Histochemistry & Cytochemistry 48 (9), 1215-1222, 2000
912000
Expression of erythropoietin and erythropoietin receptor in non–small cell lung carcinomas
K Dagnon, E Pacary, F Commo, M Antoine, M Bernaudin, JF Bernaudin, ...
Clinical cancer research 11 (3), 993-999, 2005
902005
Targeting the deregulated spliceosome core machinery in cancer cells triggers mTOR blockade and autophagy
V Quidville, S Alsafadi, A Goubar, F Commo, V Scott, C Pioche-Durieu, ...
Cancer research 73 (7), 2247-2258, 2013
852013
Prognostic impact of vitamin B6 metabolism in lung cancer
L Galluzzi, I Vitale, L Senovilla, KA Olaussen, G Pinna, T Eisenberg, ...
Cell reports 2 (2), 257-269, 2012
822012
MDR1-Pgp 170 expression in human bronchus
E Lechapt-Zalcman, I Hurbain, R Lacave, F Commo, T Urban, M Antoine, ...
European Respiratory Journal 10 (8), 1837-1843, 1997
791997
Clinical impact of the NKp30/B7-H6 axis in high-risk neuroblastoma patients
M Semeraro, S Rusakiewicz, V Minard-Colin, NF Delahaye, D Enot, ...
Science translational medicine 7 (283), 283ra55-283ra55, 2015
712015
DNA damage repair and telomere length in normal breast, preneoplastic lesions, and invasive cancer
CM Raynaud, J Hernandez, FP Llorca, P Nuciforo, MC Mathieu, F Commo, ...
American journal of clinical oncology 33 (4), 341-345, 2010
672010
Histopathological validation of the sentinel node concept in cervical cancer
E Barranger, A Cortez, F Commo, O Marpeau, S Uzan, E Darai, P Callard
Annals of oncology 15 (6), 870-874, 2004
652004
Molecular characteristics of ERCC1-negative versus ERCC1-positive tumors in resected NSCLC
L Friboulet, D Barrios-Gonzales, F Commo, KA Olaussen, S Vagner, ...
Clinical Cancer Research 17 (17), 5562-5572, 2011
642011
Type 1 plasminogen activator inhibitor deficiency aggravates the course of experimental glomerulonephritis through overactivation of transforming growth factor beta
A Hertig, J Berrou, Y Allory, L Breton, F Commo, MAC De Beauregard, ...
The FASEB journal 17 (13), 1904-1906, 2003
632003
Type 1 plasminogen activator inhibitor deficiency aggravates the course of experimental glomerulonephritis through overactivation of transforming growth factor beta
A Hertig, J Berrou, Y Allory, L Breton, F Commo, MAC De Beauregard, ...
The FASEB journal 17 (13), 1904-1906, 2003
632003
Synergistic proapoptotic effects of the two tyrosine kinase inhibitors pazopanib and lapatinib on multiple carcinoma cell lines
KA Olaussen, F Commo, M Tailler, L Lacroix, I Vitale, SQ Raza, C Richon, ...
Oncogene 28 (48), 4249, 2009
622009
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20